2-cyclopentyl-N-[3-(3-sulfinamoylphenyl)-1H-indazol-5-yl]acetamide

C20H22N4O2S — CID 123612503

IUPAC2-cyclopentyl-N-[3-(3-sulfinamoylphenyl)-1H-indazol-5-yl]acetamide
SMILESNS(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)CC4CCCC4)cc23)c1
InChIInChI=1S/C20H22N4O2S/c21-27(26)16-7-3-6-14(11-16)20-17-12-15(8-9-18(17)23-24-20)22-19(25)10-13-4-1-2-5-13/h3,6-9,11-13H,1-2,4-5,10,21H2,(H,22,25)(H,23,24)
InChIKeyWSXGTUAKVYENFQ-UHFFFAOYSA-N
MW382.49 g/mol
LogP3.73
Rot. Bonds5

About 2-cyclopentyl-N-[3-(3-sulfinamoylphenyl)-1H-indazol-5-yl]acetamide

2-cyclopentyl-N-[3-(3-sulfinamoylphenyl)-1H-indazol-5-yl]acetamide (PubChem CID 123612503) has the molecular formula C20H22N4O2S and a molecular weight of 382.49 g/mol. Its IUPAC name is 2-cyclopentyl-N-[3-(3-sulfinamoylphenyl)-1H-indazol-5-yl]acetamide.

Molecular Properties

Compound Name2-cyclopentyl-N-[3-(3-sulfinamoylphenyl)-1H-indazol-5-yl]acetamide
PubChem CID123612503
Molecular FormulaC20H22N4O2S
Molecular Weight382.49 g/mol
Exact Mass382.15
IUPAC Name2-cyclopentyl-N-[3-(3-sulfinamoylphenyl)-1H-indazol-5-yl]acetamide
SMILESNS(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)CC4CCCC4)cc23)c1
InChIInChI=1S/C20H22N4O2S/c21-27(26)16-7-3-6-14(11-16)20-17-12-15(8-9-18(17)23-24-20)22-19(25)10-13-4-1-2-5-13/h3,6-9,11-13H,1-2,4-5,10,21H2,(H,22,25)(H,23,24)
InChIKeyWSXGTUAKVYENFQ-UHFFFAOYSA-N
XLogP3.73
TPSA100.87 Ų
H-Bond Donors3
H-Bond Acceptors3
Rotatable Bonds5
Heavy Atoms27
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500382.49
LogP ≤ 53.73
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 103

Analyze 2-cyclopentyl-N-[3-(3-sulfinamoylphenyl)-1H-indazol-5-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-cyclopentyl-N-[3-(6-oxo-1H-pyridazin-3-yl)phenyl]acetamide
CID 51100304
2-cyclopentyl-N-pyridin-4-ylacetamide
CID 11839759
2-cyclopentyl-N-(1H-indazol-3-yl)acetamide
CID 55023308
2-cyclopentyl-N-[6-(3-fluorophenyl)-1H-indazol-3-yl]acetamide
CID 69060880
2-cyclohexyl-N-(3-phenylphenyl)acetamide
CID 53348155
2-cyclohexyl-N-[5-[3-(4-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide
CID 137112220
2-cyclohexyl-N-[5-[3-[4-(3-fluorophenyl)-1H-indol-2-yl]-6-iodo-1H-indazol-5-yl]-3-pyridinyl]acetamide
CID 137103287
2-cyclopentyl-N-(1H-indazol-6-yl)acetamide
CID 47110222
2-cyclopropyl-N-[3-(1H-pyrazol-5-yl)phenyl]acetamide
CID 37044565
(2S)-N-[3-(3-sulfamoylphenyl)-1H-indazol-5-yl]pyrrolidine-2-carboxamide
CID 67455130
2-cyclohexyl-N-(2-phenyl-3H-benzimidazol-5-yl)acetamide
CID 163397662
2-cyclopentyl-N-[6-(4-fluorophenyl)-1H-indazol-3-yl]acetamide
CID 69060428

Frequently Asked Questions

What is the IUPAC name of 2-cyclopentyl-N-[3-(3-sulfinamoylphenyl)-1H-indazol-5-yl]acetamide?
The IUPAC name of 2-cyclopentyl-N-[3-(3-sulfinamoylphenyl)-1H-indazol-5-yl]acetamide (CID 123612503) is 2-cyclopentyl-N-[3-(3-sulfinamoylphenyl)-1H-indazol-5-yl]acetamide.
What is the SMILES notation for 2-cyclopentyl-N-[3-(3-sulfinamoylphenyl)-1H-indazol-5-yl]acetamide?
The canonical SMILES for 2-cyclopentyl-N-[3-(3-sulfinamoylphenyl)-1H-indazol-5-yl]acetamide is NS(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)CC4CCCC4)cc23)c1.
What is the InChIKey of 2-cyclopentyl-N-[3-(3-sulfinamoylphenyl)-1H-indazol-5-yl]acetamide?
The InChIKey is WSXGTUAKVYENFQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H22N4O2S/c21-27(26)16-7-3-6-14(11-16)20-17-12-15(8-9-18(17)23-24-20)22-19(25)10-13-4-1-2-5-13/h3,6-9,11-13H,1-2,4-5,10,21H2,(H,22,25)(H,23,24).
What are the key properties of 2-cyclopentyl-N-[3-(3-sulfinamoylphenyl)-1H-indazol-5-yl]acetamide?
2-cyclopentyl-N-[3-(3-sulfinamoylphenyl)-1H-indazol-5-yl]acetamide has a molecular weight of 382.49 g/mol, XLogP of 3.73, 5 rotatable bonds, 3 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 2-cyclopentyl-N-[3-(3-sulfinamoylphenyl)-1H-indazol-5-yl]acetamide is sourced from PubChem (CID 123612503), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).